AC
DXCM icon

Allstate Corporation’s DexCom DXCM Stock Holding History

Allstate Corporation’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Buy
52,792
+23,830
+82% +$1.66M 0.04% 338
2025
Q4 		$1.92M Buy
28,962
+14,639
+102% +$946K 0.03% 373
2025
Q3 		$964K Buy
+14,323
New +$1.13M 0.02% 364
2025
Q2 		– Sell
-15,631
Closed -$1.07M – 285
2025
Q1 		$1.07M Buy
15,631
+3,781
+32% +$309K 0.03% 330
2024
Q4 		$922K Buy
+11,850
New +$877K 0.03% 336
2023
Q1 		– Sell
-16,863
Closed -$1.91M – 313
2022
Q4 		$1.91M Buy
16,863
+371
+2% +$40.7K 0.06% 200
2022
Q3 		$1.33M Sell
16,492
-3,920
-19% -$332K 0.04% 263
2022
Q2 		$1.52M Buy
20,412
+10,116
+98% +$923K 0.05% 230
2022
Q1 		$1.32M Buy
10,296
+784
+8% +$85.8K 0.04% 342
2021
Q4 		$1.28M Buy
9,512
+80
+0.8% +$11.5K 0.02% 485
2021
Q3 		$1.29M Sell
9,432
-968
-9% -$122K 0.05% 225
2021
Q2 		$1.11M Buy
10,400
+1,104
+12% +$106K 0.04% 280
2021
Q1 		$835K Buy
9,296
+924
+11% +$86.7K 0.03% 365
2020
Q4 		$774K Sell
8,372
-1,452
-15% -$130K 0.02% 335
2020
Q3 		$1.01M Sell
9,824
-1,032
-10% -$108K 0.03% 237
2020
Q2 		$1.1M Sell
10,856
-144
-1% -$12.9K 0.04% 230
2020
Q1 		$740K Sell
11,000
-17,676
-62% -$1.1M 0.03% 273
2019
Q4 		$1.57M Buy
28,676
+612
+2% +$29K 0.03% 353
2019
Q3 		$1.05M Buy
28,064
+22,516
+406% +$875K 0.02% 382
2019
Q2 		$208K Sell
5,548
-2,760
-33% -$86.8K ﹤0.01% 473
2019
Q1 		$247K Buy
+8,308
New +$292K 0.01% 393

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allstate Corporation's DXCM Position: Q1 2026 in Review

Allstate Corporation increased its DexCom (DXCM) stake by 82% in Q1 2026, buying an estimated $1.66M and bringing the position to 52,792 shares worth $3.32M. The position accounts for 0.04% of the portfolio, ranked #338.

Allstate Corporation first reported a position in DXCM in Q1 2019 and has held it in 21 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Allstate Corporation held 52,792 shares of DexCom worth $3.32M as of Q1 2026.
  • Allstate Corporation bought 23,830 DexCom shares in Q1 2026, an estimated $1.66M.
  • DexCom made up 0.04% of Allstate Corporation's portfolio in Q1 2026, its #338 holding.
  • Allstate Corporation first reported a position in DexCom in Q1 2019 and has held it in 21 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.